. Author manuscript; available in PMC: 2013 Oct 28.

Published in final edited form as: Virology. 2011 May 8;415(1):10.1016/j.virol.2011.04.004. doi: 10.1016/j.virol.2011.04.004

Table 1.

CTCF and cohesin occupancy of the Raji EBV genome.

CTCF-binding sites	RAD21-binding sites	Nearby transcriptional regulatory element^a
6411–6580		EBER-1 (pol III transcript) [misc RNA]
10483–10633		C promoter (Cp) used in latency III [TATA signal]
35899–36054	35902–36081	EBNA-LP, W promoter (Wp) used in earlier stages of latent infection [TATA signal]
50019–50166	50010–50164	EBNA-1, QUK transcript, starts from the Q promoter (Qp) in latency I [mRNA]
63435–63584		BOLF1 [TATA signal]
67872–68022	67892–68041	BMRF1 [TATA signal]
75554–75705		BLRF1 [TATA signal]
91180–91331	91189–91339	BZLF1 [TATA signal]
116241–116386	116213–116378	BGLF1 [TATA signal]
122920–123090		BDLF1 [TATA signal]
133362–133528		BVRF1 [TATA signal]
138827–139018		RPMS1, BART mRNAs [mRNA]
145778–145959		LF3 [TATA signal]
166435–166588	166416–166570	LMP-2A [TATA signal]
168369–168541		LMP-1 [TATA signal]

From the human herpesvirus 4 complete genome sequence (Genbank ID: NC_007605.1).